Who owns Exelixis?

Key details on Exelixis (Ticker: EXEL)

Who owns Exelixis?

Is EXEL a good stock to own? Find out who bought Exelixis, who sold Exelixis (EXEL) stock, and who holds a large position in Exelixis.

Fund Name Number of Shares Share Valuation As Of
FMR 34.23M $136.91M March 31, 2016
T. Rowe Price Associates 24.96M $99.86M March 31, 2016
Capital Research Global Investors^ 22.57M $138.32M Dec. 31, 2013
Meditor 22.07M $88.28M March 31, 2016
Wellington Management Company 16.24M $55.06M June 30, 2014
Vanguard 15.62M $88.10M Dec. 31, 2015
BlackRock Fund Advisors 9.63M $38.52M March 31, 2016
OrbiMed Advisors 9.39M $57.55M Dec. 31, 2013
STATE STREET CORPORATION 8.43M $33.70M March 31, 2016
Inves 7.15M $28.58M March 31, 2016
CITADEL ADVISORS 7.10M $40.03M Dec. 31, 2015
BNP PARIBAS ARBITRAGE, SNC 6.84M $616.42M March 31, 2014
BlackRock Institutional Trust Company, N.A. 5.33M $21.32M March 31, 2016
BVF 4.99M $12.82M March 31, 2015
GOLDMAN SACHS 4.11M $16.44M March 31, 2016
Deerfield Management Company 4.00M $10.28M March 31, 2015
Dr. Jeffrey R. Jay, M.D. 3.90M $15.58M March 31, 2016